Imagine the Possibilities Together
FDA and industry are working collaboratively to advance the use (and usefulness) of AI across the pharmaceutical and medical device industries. Over the past century, our industries have amassed data that largely remains untapped. Through the power of AI, we can now make decisions with more robust data and information than ever before. We can identify medical solutions that will improve quality of life, prevent illness and cure diseases. We can predict failures to increase the assurance of product quality and business efficiency. We are on the cusp of revolutionizing healthful living for today and tomorrow!
To lead and inspire the medical device and pharmaceutical industries to collaboratively advance the use of artificial intelligence so as to advance patient health, product quality and process improvement.
To challenge and advance the current thinking on patient health, product quality and process improvement in the pharmaceutical and medical device industries through the power of AI.
To develop practical artificial intelligence solutions across the pharmaceutical and medical device industries, and to make those solutions available to the global industry.
FDA/Industry Working Teams
Through the Xavier Artificial Intelligence Initiative, chartered working teams have been established during the face-to-face setting of the annual Xavier AI Summit. The teams that are currently formed are as follows, and are accepting new members: